China Resources Pharmaceutical Group Ltd. (3320.HK) Stock Competitors & Peer Comparison
See (3320.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 3320.HK | HK$4.31 | -2.71% | 27.1B | 6.09 | HK$0.71 | +8.28% |
| 1177.HK | HK$4.26 | +0.00% | 76B | 28.07 | HK$0.15 | +2.35% |
| 3759.HK | HK$17.30 | +3.28% | 47.2B | 16.48 | HK$1.05 | +1.26% |
| 9995.HK | HK$69.65 | -0.57% | 38.5B | 27.11 | HK$2.57 | N/A |
| 0512.HK | HK$4.57 | -1.72% | 16B | 7.70 | HK$0.59 | +3.70% |
| 2005.HK | HK$2.11 | -2.31% | 6.1B | 13.16 | HK$0.16 | +3.79% |
| 0775.HK | HK$0.59 | -1.67% | 5.7B | -44.80 | -HK$0.01 | N/A |
| 3613.HK | HK$6.21 | -2.36% | 5.2B | 8.32 | HK$0.75 | +6.44% |
| 1345.HK | HK$2.25 | +0.00% | 2.6B | 16.17 | HK$0.14 | +5.24% |
| 0950.HK | HK$1.04 | -3.70% | 612.4M | 8.00 | HK$0.13 | +4.33% |
Stock Comparison
3320.HK vs 1177.HK Comparison June 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 27.1B. In comparison, 1177.HK has a market cap of 76B. Regarding current trading prices, 3320.HK is priced at HK$4.31, while 1177.HK trades at HK$4.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.09, whereas 1177.HK's P/E ratio is 28.07. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 1177.HK's ROE of +0.07%. Regarding short-term risk, 3320.HK is less volatile compared to 1177.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 1177.HK's competition here
3320.HK vs 3759.HK Comparison June 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 27.1B. In comparison, 3759.HK has a market cap of 47.2B. Regarding current trading prices, 3320.HK is priced at HK$4.31, while 3759.HK trades at HK$17.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.09, whereas 3759.HK's P/E ratio is 16.48. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 3759.HK's ROE of +0.11%. Regarding short-term risk, 3320.HK is less volatile compared to 3759.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 3759.HK's competition here
3320.HK vs 9995.HK Comparison June 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 27.1B. In comparison, 9995.HK has a market cap of 38.5B. Regarding current trading prices, 3320.HK is priced at HK$4.31, while 9995.HK trades at HK$69.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.09, whereas 9995.HK's P/E ratio is 27.11. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 9995.HK's ROE of +0.42%. Regarding short-term risk, 3320.HK is less volatile compared to 9995.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 9995.HK's competition here
3320.HK vs 0512.HK Comparison June 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 27.1B. In comparison, 0512.HK has a market cap of 16B. Regarding current trading prices, 3320.HK is priced at HK$4.31, while 0512.HK trades at HK$4.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.09, whereas 0512.HK's P/E ratio is 7.70. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 0512.HK's ROE of +0.07%. Regarding short-term risk, 3320.HK is more volatile compared to 0512.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 0512.HK's competition here
3320.HK vs 2005.HK Comparison June 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 27.1B. In comparison, 2005.HK has a market cap of 6.1B. Regarding current trading prices, 3320.HK is priced at HK$4.31, while 2005.HK trades at HK$2.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.09, whereas 2005.HK's P/E ratio is 13.16. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 2005.HK's ROE of +0.06%. Regarding short-term risk, 3320.HK is more volatile compared to 2005.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 2005.HK's competition here
3320.HK vs 0775.HK Comparison June 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 27.1B. In comparison, 0775.HK has a market cap of 5.7B. Regarding current trading prices, 3320.HK is priced at HK$4.31, while 0775.HK trades at HK$0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.09, whereas 0775.HK's P/E ratio is -44.80. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 0775.HK's ROE of -0.05%. Regarding short-term risk, 3320.HK is more volatile compared to 0775.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 0775.HK's competition here
3320.HK vs 3613.HK Comparison June 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 27.1B. In comparison, 3613.HK has a market cap of 5.2B. Regarding current trading prices, 3320.HK is priced at HK$4.31, while 3613.HK trades at HK$6.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.09, whereas 3613.HK's P/E ratio is 8.32. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 3613.HK's ROE of +0.10%. Regarding short-term risk, 3320.HK is more volatile compared to 3613.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 3613.HK's competition here
3320.HK vs 1345.HK Comparison June 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 27.1B. In comparison, 1345.HK has a market cap of 2.6B. Regarding current trading prices, 3320.HK is priced at HK$4.31, while 1345.HK trades at HK$2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.09, whereas 1345.HK's P/E ratio is 16.17. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 1345.HK's ROE of +0.11%. Regarding short-term risk, 3320.HK is more volatile compared to 1345.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 1345.HK's competition here
3320.HK vs 0950.HK Comparison June 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 27.1B. In comparison, 0950.HK has a market cap of 612.4M. Regarding current trading prices, 3320.HK is priced at HK$4.31, while 0950.HK trades at HK$1.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.09, whereas 0950.HK's P/E ratio is 8.00. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 0950.HK's ROE of +0.05%. Regarding short-term risk, 3320.HK is less volatile compared to 0950.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 0950.HK's competition here
3320.HK vs 3390.HK Comparison June 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 27.1B. In comparison, 3390.HK has a market cap of 214.6M. Regarding current trading prices, 3320.HK is priced at HK$4.31, while 3390.HK trades at HK$0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.09, whereas 3390.HK's P/E ratio is 57.69. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 3390.HK's ROE of +0.03%. Regarding short-term risk, 3320.HK is more volatile compared to 3390.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 3390.HK's competition here
3320.HK vs 1110.HK Comparison June 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 27.1B. In comparison, 1110.HK has a market cap of 212.3M. Regarding current trading prices, 3320.HK is priced at HK$4.31, while 1110.HK trades at HK$0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.09, whereas 1110.HK's P/E ratio is 4.71. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 1110.HK's ROE of +0.02%. Regarding short-term risk, 3320.HK is less volatile compared to 1110.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 1110.HK's competition here
3320.HK vs 8225.HK Comparison June 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 27.1B. In comparison, 8225.HK has a market cap of 100.5M. Regarding current trading prices, 3320.HK is priced at HK$4.31, while 8225.HK trades at HK$0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.09, whereas 8225.HK's P/E ratio is -5.05. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 8225.HK's ROE of -0.36%. Regarding short-term risk, 3320.HK is more volatile compared to 8225.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 8225.HK's competition here
3320.HK vs 0574.HK Comparison June 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 27.1B. In comparison, 0574.HK has a market cap of 43.8M. Regarding current trading prices, 3320.HK is priced at HK$4.31, while 0574.HK trades at HK$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.09, whereas 0574.HK's P/E ratio is -0.51. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 0574.HK's ROE of +0.11%. Regarding short-term risk, 3320.HK is less volatile compared to 0574.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 0574.HK's competition here
3320.HK vs 6108.HK Comparison June 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 27.1B. In comparison, 6108.HK has a market cap of 40.1M. Regarding current trading prices, 3320.HK is priced at HK$4.31, while 6108.HK trades at HK$0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.09, whereas 6108.HK's P/E ratio is -1.67. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 6108.HK's ROE of N/A. Regarding short-term risk, 3320.HK is more volatile compared to 6108.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 6108.HK's competition here
3320.HK vs 2211.HK Comparison June 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 27.1B. In comparison, 2211.HK has a market cap of 39.5M. Regarding current trading prices, 3320.HK is priced at HK$4.31, while 2211.HK trades at HK$0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.09, whereas 2211.HK's P/E ratio is 18.87. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 2211.HK's ROE of -0.07%. Regarding short-term risk, 3320.HK is less volatile compared to 2211.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 2211.HK's competition here
3320.HK vs 1889.HK Comparison June 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 27.1B. In comparison, 1889.HK has a market cap of 26M. Regarding current trading prices, 3320.HK is priced at HK$4.31, while 1889.HK trades at HK$0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.09, whereas 1889.HK's P/E ratio is -1.00. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 1889.HK's ROE of N/A. Regarding short-term risk, 3320.HK is less volatile compared to 1889.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 1889.HK's competition here